Clinical Trials on Primary+Immunodeficiency+Diseases
Total 383668 results
-
AbbottCompleted
-
AbbVieCompletedHuman Immunodeficiency Virus (HIV)United States, Puerto Rico
-
Olayemi Osiyemi MDCompletedAcquired Immunodeficiency Syndrome | Human Immunodeficiency Virus TypeUnited States
-
National Center for Complementary and Integrative...CompletedHuman Immunodeficiency Virus | AIDSUnited States
-
medac GmbHSyneos Health; Celerion; Venn Life SciencesCompletedBone Marrow Failure Syndromes | Inborn Errors of Metabolism | Primary Immunodeficiencies | HaemoglobinopathiesPoland, Czechia, Germany, Italy
-
University of South FloridaJohns Hopkins University; Baylor College of Medicine; Boston Children's Hospital and other collaboratorsCompleted
-
St Vincent's Hospital, SydneyMerck Sharp & Dohme LLCTerminatedHuman Immunodeficiency Virus (HIV) | HIV Associated Neurocognitive Disorders (HAND)Australia
-
Institut National de la Santé Et de la Recherche...TerminatedCommon Variable ImmunodeficiencyFrance
-
Ottawa Heart Institute Research CorporationOntario HIV Treatment NetworkCompletedHuman Immunodeficiency Virus (HIV) | Cardiovascular Disease (CVD)Canada
-
Hopital FochSiemens Healthcare QTRecruiting
-
Green Cross CorporationAtlantic Research GroupRecruitingPrimary Immune DeficiencyUnited States
-
Imagine InstituteAssistance Publique - Hôpitaux de ParisCompletedPrimary Immuno-DeficienciesFrance
-
CSL BehringCompletedPrimary Immune DeficiencyUnited States
-
Universiti Teknologi MaraCompletedHuman Immunodeficiency VirusMalaysia
-
ViiV HealthcareAvailable
-
Queen Mary University of LondonGuy's and St Thomas' NHS Foundation Trust; Barts & The London NHS Trust; Royal... and other collaboratorsActive, not recruitingHuman Immunodeficiency VirusesUnited Kingdom
-
Janssen Research & Development, LLCCompletedHuman Immunodeficiency Virus (HIV)United States, Spain, South Africa
-
VA Office of Research and DevelopmentCompletedSmoking | Human Immunodeficiency VirusUnited States
-
Seagen Inc.WithdrawnHuman Immunodeficiency VirusUnited States
-
Imperial College LondonCompletedHuman Immunodeficiency VirusUnited Kingdom
-
Janssen Vaccines & Prevention B.V.Beth Israel Deaconess Medical Center; US Military HIV Research Program; Ragon...CompletedHuman Immunodeficiency VirusUnited States
-
University of Alabama at BirminghamCompleted
-
AbbVie (prior sponsor, Abbott)Veeda Clinical ResearchCompletedHuman Immunodeficiency Virus
-
Johns Hopkins UniversityNational Institutes of Health (NIH)CompletedHuman Immunodeficiency VirusUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompletedHuman Immunodeficiency VirusFrance
-
PfizerWithdrawnHuman Immunodeficiency Virus
-
Imperial College LondonCompletedHuman Immunodeficiency VirusUnited Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedEffect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy SubjectsInfection, Human Immunodeficiency VirusUnited States
-
CSL LimitedCompletedPrimary Immune Deficiency (PID)Australia
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
Kerti Praja FoundationUnited NationsUnknownHuman Immunodeficiency Virus (HIV)Indonesia
-
St. Hope FoundationGlaxoSmithKlineCompleted
-
Justine BolesEuropean and Developing Countries Clinical Trials Partnership (EDCTP)CompletedHIV | Human Immunodeficiency VirusKenya, Malawi, Uganda, Zambia, Zimbabwe
-
RetroLead (Shanghai) BioPharma Co., Ltd.Not yet recruitingHuman Immunodeficiency Virus-1 (HIV-1) Infection
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
Janssen Infectious Diseases BVBACompletedHuman Immunodeficiency Virus Type 1Belgium
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency Virus IUnited States, Canada, Puerto Rico
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusGermany
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IUnited States, Spain, Germany, Australia, Canada, Belgium, Denmark, Netherlands, United Kingdom, France, Italy, Romania
-
AbbVie (prior sponsor, Abbott)CompletedHuman Immunodeficiency Virus Infection
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
Janssen-Cilag G.m.b.HCompletedHuman Immunodeficiency Virus (HIV)Germany